Literature DB >> 8690298

Establishment and characterization of three new cell lines derived from the ascites of human ovarian carcinomas.

A Alama1, F Barbieri, A Favre, M Cagnoli, E Noviello, F Pedullà, M Viale, G Foglia, N Ragni.   

Abstract

Three human cancer cell lines (OC 314, OC 315, and OC 316) were newly established in permanent culture from the ascites of patients with serous adenocarcinoma of the ovary. OC 314 was derived from an untreated tumor presenting with ascites at diagnosis; OC 315 was isolated from a neoplasm progressing after cisplatin-containing regimen; and OC 316 was collected from a patient with pleural metastasis at diagnosis, resistant to different chemotherapeutic treatments including Taxol. These cell lines were repetitively subcultured once to twice a week through 75-80 passage generations. Tumor cells grew as monolayers and displayed epithelial-like morphology, consistent with a feature of adenocarcinoma, which was then confirmed by the expressions of cytokeratins and vimentin. The cell lines proved highly tumorigenic when transplanted into nude mice, both subcutaneously and intraperitoneally. In addition, the mice inoculated with subcutaneous OC 316 developed extremely aggressive tumor, also invading the peritoneum, which correlated with the malignant behavior of the original tumor. Drug sensitivity, evaluated by the MTT assay, showed that the three cell lines expressed similar sensitivity to doxorubicin. Responses to cisplatin essentially reported low sensitivity of OC 314 and OC 315 and resistance of OC 316, thus reflecting the original sensitivity at the clinical level.

Entities:  

Mesh:

Year:  1996        PMID: 8690298     DOI: 10.1006/gyno.1996.0194

Source DB:  PubMed          Journal:  Gynecol Oncol        ISSN: 0090-8258            Impact factor:   5.482


  14 in total

1.  Characterization of four novel epithelial ovarian cancer cell lines.

Authors:  D M Provencher; H Lounis; L Champoux; M Tétrault; E N Manderson; J C Wang; P Eydoux; R Savoie; P N Tonin; A M Mes-Masson
Journal:  In Vitro Cell Dev Biol Anim       Date:  2000-06       Impact factor: 2.416

2.  Establishment of a New Ovarian Cancer Cell Line CA5171.

Authors:  Ying-Cheng Chiang; Wen-Fang Cheng; Ming-Cheng Chang; Tzu-Pin Lu; Kuan-Ting Kuo; Hsiu-Ping Lin; Chang-Yao Hsieh; Chi-An Chen
Journal:  Reprod Sci       Date:  2014-11-12       Impact factor: 3.060

3.  BRCA1/2 mutation analysis in 41 ovarian cell lines reveals only one functionally deleterious BRCA1 mutation.

Authors:  Britta Stordal; Kirsten Timms; Angela Farrelly; Danielle Gallagher; Steven Busschots; Mickaël Renaud; Julien Thery; Deborah Williams; Jennifer Potter; Thanh Tran; Greg Korpanty; Mattia Cremona; Mark Carey; Jie Li; Yang Li; Ozlem Aslan; John J O'Leary; Gordon B Mills; Bryan T Hennessy
Journal:  Mol Oncol       Date:  2013-01-31       Impact factor: 6.603

4.  Establishment and characterization of a platinum- and paclitaxel-resistant high grade serous ovarian carcinoma cell line.

Authors:  Pang-Ning Teng; Nicholas W Bateman; Guisong Wang; Tracy Litzi; Brian E Blanton; Brian L Hood; Kelly A Conrads; Wei Ao; Kate E Oliver; Kathleen M Darcy; William P McGuire; Keren Paz; David Sidransky; Chad A Hamilton; G Larry Maxwell; Thomas P Conrads
Journal:  Hum Cell       Date:  2017-03-01       Impact factor: 4.174

5.  Manipulation of tumor metabolism for therapeutic approaches: ovarian cancer-derived cell lines as a model system.

Authors:  Kristina Goetze; Christian G Fabian; Andrea Siebers; Livia Binz; Daniel Faber; Stefano Indraccolo; Giorgia Nardo; Ulrike G A Sattler; Wolfgang Mueller-Klieser
Journal:  Cell Oncol (Dordr)       Date:  2015-08-19       Impact factor: 6.730

6.  Genomic and proteomic characterization of YDOV-157, a newly established human epithelial ovarian cancer cell line.

Authors:  HanByoul Cho; Eun Suk Kang; Soon Won Hong; Youn Jin Oh; Sun Mi Choi; Sang Wun Kim; Sung Hoon Kim; Young Tae Kim; Kyoung Sun Lee; Yang Kyu Choi; Jae-Hoon Kim
Journal:  Mol Cell Biochem       Date:  2008-08-06       Impact factor: 3.396

7.  Expression of cyclin D1 correlates with malignancy in human ovarian tumours.

Authors:  F Barbieri; M Cagnoli; N Ragni; F Pedullà; G Foglia; A Alama
Journal:  Br J Cancer       Date:  1997       Impact factor: 7.640

8.  Characterization of three new serous epithelial ovarian cancer cell lines.

Authors:  Véronique Ouellet; Magdalena Zietarska; Lise Portelance; Julie Lafontaine; Jason Madore; Marie-Line Puiffe; Suzanna L Arcand; Zhen Shen; Josée Hébert; Patricia N Tonin; Diane M Provencher; Anne-Marie Mes-Masson
Journal:  BMC Cancer       Date:  2008-05-28       Impact factor: 4.430

9.  Response to microtubule-interacting agents in primary epithelial ovarian cancer cells.

Authors:  Ilenia Pellicciotta; Chia-Ping Huang Yang; Charis A Venditti; Gary L Goldberg; Shohreh Shahabi
Journal:  Cancer Cell Int       Date:  2013-04-10       Impact factor: 5.722

10.  A Novel Compound ARN-3236 Inhibits Salt-Inducible Kinase 2 and Sensitizes Ovarian Cancer Cell Lines and Xenografts to Paclitaxel.

Authors:  Jinhua Zhou; Albandri Alfraidi; Shu Zhang; Janice M Santiago-O'Farrill; Venkata Krishna Yerramreddy Reddy; Abdulkhaliq Alsaadi; Ahmed A Ahmed; Hailing Yang; Jinsong Liu; Weiqun Mao; Yan Wang; Hiroshi Takemori; Hariprasad Vankayalapati; Zhen Lu; Robert C Bast
Journal:  Clin Cancer Res       Date:  2016-09-27       Impact factor: 12.531

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.